Alyeska Investment Group »

Parabilis Medicines shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $274k 10k 27.37

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
salesforce (CRM)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Intuitive Surgical Com New (ISRG)
Amazon (AMZN)
Amphenol Corp Cl A (APH)
Gpgi Com Cl A (GPGI)
Spotify Technology S A SHS (SPOT)
Analog Devices (ADI)
Burlington Stores (BURL)
Zebra Technologies Corporati Cl A (ZBRA)
Merck & Co (MRK)

View all positions for Alyeska Investment Group

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines